Accelerating investments in biotechnology have propelled the Neulasta Pegfilgrastim And Biosimilar Market into a new era of clinical accessibility and operational scalability. As cancer treatment paradigms increasingly incorporate multi-agent chemotherapy regimens, managing side effects like profound white blood cell depletion has become a core priority for medical oncologists. The massive...